[go: up one dir, main page]

ATE350382T1 - Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden - Google Patents

Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden

Info

Publication number
ATE350382T1
ATE350382T1 AT04779031T AT04779031T ATE350382T1 AT E350382 T1 ATE350382 T1 AT E350382T1 AT 04779031 T AT04779031 T AT 04779031T AT 04779031 T AT04779031 T AT 04779031T AT E350382 T1 ATE350382 T1 AT E350382T1
Authority
AT
Austria
Prior art keywords
imidazopyrimidines
triazolopyrimidines
receptor ligands
benzodiazepine receptor
benzodiazepine
Prior art date
Application number
AT04779031T
Other languages
English (en)
Inventor
Linghong Xie
Bingsong Han
Yuelian Xu
George Maynard
Bertrand L Chenard
Kenneth Shaw
Yang Gao
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Application granted granted Critical
Publication of ATE350382T1 publication Critical patent/ATE350382T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04779031T 2003-07-25 2004-07-23 Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden ATE350382T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49000603P 2003-07-25 2003-07-25
US54308304P 2004-02-09 2004-02-09

Publications (1)

Publication Number Publication Date
ATE350382T1 true ATE350382T1 (de) 2007-01-15

Family

ID=34118813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04779031T ATE350382T1 (de) 2003-07-25 2004-07-23 Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden

Country Status (20)

Country Link
US (2) US7271170B2 (de)
EP (1) EP1648899B1 (de)
JP (1) JP2007500130A (de)
KR (1) KR20060098425A (de)
AR (1) AR045117A1 (de)
AT (1) ATE350382T1 (de)
AU (1) AU2004261591A1 (de)
BR (1) BRPI0412908A (de)
CA (1) CA2537331A1 (de)
CY (1) CY1107565T1 (de)
DE (1) DE602004004143T2 (de)
DK (1) DK1648899T3 (de)
ES (1) ES2278345T3 (de)
IL (1) IL173265A0 (de)
MX (1) MXPA06000887A (de)
NZ (1) NZ544262A (de)
PL (1) PL1648899T3 (de)
PT (1) PT1648899E (de)
TW (1) TW200524937A (de)
WO (1) WO2005012306A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1619948A4 (de) * 2003-05-05 2007-02-14 Neurogen Corp Substituierte imidazolpyrazin- und triazolpyrazinderivate: gabaa-rezeptor-liganden
WO2006093911A2 (en) * 2005-03-02 2006-09-08 Neurogen Corporation Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives
JP2009507032A (ja) 2005-09-02 2009-02-19 アボット・ラボラトリーズ 新規なイミダゾ系複素環
JP2010523716A (ja) * 2007-04-11 2010-07-15 サイプレス バイオサイエンシズ，インク． ベンゾジアゼピン受容体拮抗薬を用いるダウン症候群の治療
WO2008130951A1 (en) * 2007-04-17 2008-10-30 Bristol-Myers Squibb Company Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544057A (en) * 1895-08-06 Bill and letter file
MXPA01009949A (es) * 1999-04-02 2003-07-14 Neurogen Corp Derivados aminoalquil-imidazol arilo y heteroarilo fusionados, moduladores selectivos de los receptores gaba a.
US6737242B1 (en) * 1999-05-07 2004-05-18 Neurogen Corporation Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9929687D0 (en) 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
WO2002002557A2 (en) 2000-06-30 2002-01-10 Neurogen Corporation 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
GB0027561D0 (en) * 2000-11-10 2000-12-27 Merck Sharp & Dohme Therapeutic agents
US6900215B2 (en) * 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
JP2004531499A (ja) * 2001-03-23 2004-10-14 メルク シャープ エンド ドーム リミテッド Ｇａｂａ受容体用リガンドとしてのイミダゾ−ピリミジン誘導体
IL159811A0 (en) * 2001-07-13 2004-06-20 Neurogen Corp Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
US7030144B2 (en) * 2002-05-02 2006-04-18 Neurogen Corporation Substituted imidazole derivatives: GABAA receptor ligands
WO2004041809A2 (en) * 2002-05-08 2004-05-21 Neurogen Corporation Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands
JP2006502974A (ja) * 2002-05-17 2006-01-26 ニューロジェン コーポレイション 置換環縮合イミダゾール誘導体：ｇａｂａａ受容体リガンド
CN100579579C (zh) * 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
AU2003276514A1 (en) 2002-11-08 2004-06-07 Neurogen Corporation 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors
EP1619948A4 (de) 2003-05-05 2007-02-14 Neurogen Corp Substituierte imidazolpyrazin- und triazolpyrazinderivate: gabaa-rezeptor-liganden

Also Published As

Publication number Publication date
MXPA06000887A (es) 2006-04-19
PT1648899E (pt) 2007-03-30
CY1107565T1 (el) 2013-03-13
EP1648899A2 (de) 2006-04-26
HK1089446A1 (en) 2006-12-01
DE602004004143D1 (de) 2007-02-15
NZ544262A (en) 2009-06-26
JP2007500130A (ja) 2007-01-11
BRPI0412908A (pt) 2006-09-26
US20080139580A1 (en) 2008-06-12
ES2278345T3 (es) 2007-08-01
IL173265A0 (en) 2006-06-11
EP1648899B1 (de) 2007-01-03
PL1648899T3 (pl) 2007-06-29
US7271170B2 (en) 2007-09-18
WO2005012306A2 (en) 2005-02-10
CA2537331A1 (en) 2005-02-10
WO2005012306A3 (en) 2005-04-14
KR20060098425A (ko) 2006-09-18
DK1648899T3 (da) 2007-04-02
AR045117A1 (es) 2005-10-19
AU2004261591A1 (en) 2005-02-10
US20050038043A1 (en) 2005-02-17
TW200524937A (en) 2005-08-01
DE602004004143T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
ATE272639T1 (de) Imidazopyrimidin-derivate und triazolopyrimidin- derivate
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
DK1699795T3 (da) Substituerede 8'-pyri(mi)dinyldihydrospiro[cycloalkylamin]-pyrimido[1,2-a]pyrimidin-6-onderivater
EP1734820A4 (de) Imidazopyrazine, imidazopyridine und imidazopyrimidine als crf1-rezeptorliganden
IL180757A0 (en) Imidazo[4,5-d] pyrimidines, their uses and methods of preparation
IL183110A0 (en) Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
DE50302207D1 (de) Alkyl-substituierte pyrazolopyrimidine
IL175915A0 (en) Substituted imidazo ring systems and methods
GB2404359B (en) Child vehicle seat
ZA200606615B (en) Heteroaryl-fused pyrazolo derivatives
DK1622912T3 (da) 2-alkynyl- og 2-alkenyl-pyrazolo-[4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidinadenosin-A2A-receptorantagonister
DK1430056T3 (da) Substituerede 2-pyrimidinyl - 6,7,8,9-tetrahydropyrimido-[1,2-a]pyrimidin-4-on- og 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a] pyrimidin-5 (1H) onderivater mod neurodegenerative lidelser
NO20054330D0 (no) 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
DE60217293D1 (de) Abnehmbarer Fahrzeugsitz
IL174512A0 (en) Pyrazolo and imidazo-pyrimidine derivatives
NO20054331D0 (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
IL177510A0 (en) Pyrazolopyrimidines
DE50208341D1 (de) Triazolopyrimidine
DE502004011106D1 (de) 6-arylmethyl-substituierte pyrazolopyrimidine
DE60103909D1 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
ATE350382T1 (de) Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden
DE602004004295T8 (de) 6-[(Substituiertes)]Triazolopyrimidine als Antikrebsmittel
PL372989A1 (en) Triazolopyrimidines
AU2003226725A8 (en) Pyrazolopyrimidine derivatives
GB2425309B (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1648899

Country of ref document: EP

REN Ceased due to non-payment of the annual fee